ONCOSCOPE · THE EDUCATIONAL LIBRARY

Clarity for the questions ahead.

Explore articles, educational videos, research perspectives, and answers to common questions about cancer. Knowledge can help you have a more informed conversation with your care team.

Topics
Format
Tags
Clear all

2 results

Drugs as Expanding Cancer Treatment Palette: Albendazole

Drug repurposing is quickly becoming one of the most popular trends in healthcare today. Aside from cutting research and development costs considerably, these “old drugs” are safe and efficient. One of these drugs is albendazole. Albendazole’s primary use is for treating neurocysticercosis, a disease in the nervous system caused by pork tapeworms. In addition, it is also effective in treating cystic hydatid disease in the peritoneum, lungs, and liver. It is highly effective in eliminating dog tapeworm, which causes the infection. Recently, doctors discovered albendazole’s potential in treating cancer. It contains anti-cancer properties that are potentially effective in treating terminal cancer cases. This blog post will highlight albendazole’s mode of action, side effects, and benefits. So, if you’re ready to learn more interesting facts about this drug, let’s start our discussion below.

Low-Dose Hypomethylating Agents for Myelodysplastic Syndromes (MDS)

Low-dose hypomethylating agents offer promising, well-tolerated disease control for low-risk myelodysplastic syndromes. Recent trials show decitabine achieves a 67% response rate versus 48% for azacitidine, frequently restoring transfusion independence. With a median overall survival of 33 months, low-dose therapy presents a valuable alternative for low-intermediate risk patients.

YOU DO NOT HAVE TO HAVE EVERY ANSWER

Let’s take the next step together.

A thoughtful conversation can help you understand your options and prepare for what comes next.

Request a Consultation